WebMay 19, 2024 · Last year, Cingulate (Nasdaq: CING) went public after a $25 million IPO. The 16-person company, based in Kansas City, Kansas, developed an innovative precision-timed release (PTR) drug-delivery... WebCingulate Therapeutics, LLC (CTx) is a privately held, clinical-stage biopharmaceutical company focused on the development of innovative new products utilizing the Company’s disruptive, proprietary Precision Timed Release™ (PTR™) drug delivery platform technology incorporating a proprietary Erosion Barrier Layer (EBL) enabling the creation of true once …
Cingulate Inc. (CIN) Prices 4.17M Share IPO at $6/sh
WebOct 13, 2024 · Cingulate Therapeutics' IPO date and price. Cingulate is expected to start trading on Oct. 15. The company now plans to raise $40 million by offering 4.4 million … WebApr 10, 2024 · Market Average Movement. 6.4%. 10% most volatile stocks in US Market. 16.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: CING is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 22% a week. Volatility Over Time: CING's weekly volatility has increased from 16% to 22% over the … ird govt loan
Cingulate Inc. Announces Pricing of $25.0 Million Initial ... - Yahoo!
WebSee the newest and upcoming IPOs (Initial Public Offerings) announcements and details. Quarterly Earnings Calendar Learn when companies will announce their quarterly … WebOct 8, 2024 · Cognition Therapeutics priced its IPO at the mid-point. Cognition Therapeutics raised $45.2 million by offering 3.8 million shares in the IPO at $12 each. Previously, the company planned to offer ... WebDec 8, 2024 · Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to … ird genetic testing